FUNCTIONAL MEDICINE AND NUTRITION

Prostate, </span >mesane and </ span>kidney urogenital cancers are the most common cancers of the system. In recent years, it has been determined that the death rates from these cancers have decreased with cancer preventive measures, early diagnosis and treatment. However, the incidence of these cancers has been decreasing from past to present. Proper diet and eating habits urogenital It is known to have an anti-tumoral effect on tumors. In addition, excessive and unbalanced nutrition, malnutrition, ready-made food and fast food consumption increases the risk of urogenital cancer.

There are large-scale studies evaluating the negative effects of obesity and fatty diet on prostate and bladder cancer. Obesity is the biggest environmental risk factor in the development of prostate cancer. In an American study with large participation, it was reported that the cancer progressed to a more advanced and more fatal course in patients diagnosed with prostate cancer with a body mass index over 30 kg/m2.

In a similar study, it was emphasized that the frequency of prostate cancer development decreased in patients who lost 5 or more weight in a controlled manner within 10 years.

When kidney cancers are examined, results similar to prostate cancer are observed. In other words, it has been stated that the risk of kidney cancer increases in people whose body mass index is over 30 kg/m2.

Although it is known that the incidence of prostate cancer and kidney cancer increases in obese patients, the incidence of bladder cancer is thought to be higher in malnourished, debilitated patients and patients with low body mass index. However, as a result of a large-scale study conducted by Koebnick et al. between 1995 and 2003, they emphasized that obesity slightly increased the risk of bladder cancer, but this was not statistically significant, and in a similar study, it was stated that there was no relationship between body mass index and bladder cancer. The most interesting study on this subject revealed that the incidence of TP53 gene mutation, which plays a role in the development of bladder cancer, is lower in obese and overweight patients.